Zurcher Kantonalbank (Zurich Cantonalbank) Verastem, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$1.06 - $2.1 $25,950 - $51,412	-24,482 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$2.05 - $3.2 $5,026 - $7,846	-2,452 Reduced 9.1%	24,482 $50,000
Q3 2021 Nov 15, 2021	BUY	$2.54 - $4.07 $2,387 - $3,825	940 Added 3.62%	26,934 $83,000
Q2 2021 Jul 30, 2021	BUY	$2.57 - $4.85 $5,065 - $9,559	1,971 Added 8.2%	25,994 $106,000
Q1 2021 May 03, 2021	BUY	$1.9 - $2.82 $45,643 - $67,744	24,023 New	24,023 $59,000

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$1.38 Million
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$293,760
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$122,400
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$18,268
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$6,572
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.29B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account